- Award ID
- 36E79723D0005
- Contractor
- SANDOZ INC.
- Sub-agency / office
- Department of Veterans Affairs
- Award amount
- $0
- Period of performance
- Jan 15, 2023 – —
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- PSC 6505
- Competition
- FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 2 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Obligated $0 · Potential value $766,987 · Latest action obligation $0
NEW AWARD FOR AMOXICILLIN/CLAVULANATE POTASSIUM (K) SUSPENSION WITH SANDOZ, INC. ORDERING PERIOD IS JANUARY 15, 2023, TO JANUARY 14, 2024, WITH FOUR ONE-YEAR OPTIONS.
Most recent · Modification P00013 · Sep 3, 2026 · $0 action obligation · MODIFICATION TO IMPLEMENT EO 14398 DEI DISCRIMINATION. · 36E79723D0005
Modification P00012 · Jan 8, 2026 · $0 action obligation · INCORPORATE SANDOZ 2026 SUBCONTRACTING PLAN. · 36E79723D0005
Modification P00011 · Dec 15, 2025 · $0 action obligation · EXERCISE OPTION YEAR 3 WITH NO PRICE CHANGES. · 36E79723D0005
Modification P00010 · Oct 14, 2025 · $0 action obligation · DELETE NDC FOR TWO LINE ITEMS. · 36E79723D0005
Modification P00009 · Aug 5, 2025 · $0 action obligation · ADD NEW NDC FOR TWO LINE ITEMS. · 36E79723D0005
Modification P00008 · Jan 16, 2025 · $0 action obligation · INCORPORATE CONTRACTOR'S 2025 SMALL BUSINESS SUBCONTRACTING PLAN INTO CONTRACT. · 36E79723D0005
Modification P00007 · Nov 5, 2024 · $0 action obligation · EXERCISE OPTION YEAR 2 FOR AMOXICILLIN/CLAVULANATE K SUSPENSION WITH SANDOZ, INC. PERFORMANCE PERIOD IS 1/15/2025 - 1/14/2026. · 36E79723D0005
Modification P00006 · Feb 21, 2024 · $0 action obligation · UPDATE CRF PAYMENT SUBMITTAL AND SALES REPORTING · 36E79723D0005
Modification P00005 · Feb 15, 2024 · $0 action obligation · MODIFICATION TO CHANGE POC FROM EVELYN BERGMAN TO ERIC SHINN · 36E79723D0005
Modification P00004 · Feb 1, 2024 · $0 action obligation · MODIFICATION TO ADD 2024 SUBCONTRACTING PLAN. EFF. 1/1/2024 - 12/31/2024 · 36E79723D0005
Modification P00003 · Dec 18, 2023 · $0 action obligation · MODIFICATION TO EXERCISE OPTION YEAR 1. PERIOD OF PERFORMANCE IS 1/15/2024 TO 1/14/2025. · 36E79723D0005
Modification P00002 · May 3, 2023 · $0 action obligation · ADMINISTRATIVE MODIFICATION TO ADD DRUG SUPPLY CHAIN SECURITY ACT LANGUAGE TO CONTRACT. · 36E79723D0005
Modification P00001 · Jan 11, 2023 · $0 action obligation · INCORPORATE THE 2023 APPROVED SMALL BUSINESS SUBCONTRACTING PLAN. · 36E79723D0005
Modification 0 · Nov 28, 2022 · $0 action obligation · NEW AWARD FOR AMOXICILLIN/CLAVULANATE POTASSIUM (K) SUSPENSION WITH SANDOZ, INC. ORDERING PERIOD IS JANUARY 15, 2023, TO JANUARY 14, 2024, WITH FOUR ONE-YEAR OPTIONS. · 36E79723D0005